Efficacy and Safety of Rifaximin With NAC in IBS-D

NCT04557215 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Irritable Bowel Syndrome With Diarrhea

Interventions

DRUG: Rifaximin
DRUG: N-acetylcysteine
DRUG: Placebo

Sponsor

Cedars-Sinai Medical Center

Collaborators

[object Object]